| __timestamp | Bio-Techne Corporation | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 293000 |
| Thursday, January 1, 2015 | 40853000 | 1002000 |
| Friday, January 1, 2016 | 45187000 | 888000 |
| Sunday, January 1, 2017 | 53514000 | 19623000 |
| Monday, January 1, 2018 | 55329000 | 30421000 |
| Tuesday, January 1, 2019 | 62413000 | 34794000 |
| Wednesday, January 1, 2020 | 65192000 | 28304000 |
| Friday, January 1, 2021 | 70603000 | 56886000 |
| Saturday, January 1, 2022 | 87140000 | 100894000 |
| Sunday, January 1, 2023 | 92493000 | 159765000 |
| Monday, January 1, 2024 | 96664000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, innovation is the lifeblood of success. Bio-Techne Corporation and Viridian Therapeutics, Inc. have been at the forefront of this race, each investing significantly in research and development (R&D) over the past decade. From 2014 to 2023, Bio-Techne consistently increased its R&D spending, peaking at approximately $92 million in 2023, a threefold increase from 2014. Meanwhile, Viridian's R&D investment skyrocketed by over 500%, reaching nearly $160 million in 2023. This surge underscores Viridian's aggressive push towards innovation, despite a late start compared to Bio-Techne. However, data for 2024 is incomplete, leaving room for speculation on future trends. As these companies continue to innovate, their R&D investments will likely play a pivotal role in shaping the future of biotechnology.
R&D Spending Showdown: AbbVie Inc. vs Bio-Techne Corporation
R&D Insights: How Amgen Inc. and Viridian Therapeutics, Inc. Allocate Funds
R&D Insights: How Teva Pharmaceutical Industries Limited and Viridian Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Bio-Techne Corporation
Analyzing R&D Budgets: Genmab A/S vs Viridian Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
R&D Insights: How Ionis Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Viridian Therapeutics, Inc.
R&D Spending Showdown: Wave Life Sciences Ltd. vs Viridian Therapeutics, Inc.
Novavax, Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending